Nephrotic Syndrome News and Research

RSS
Nephrotic syndrome is characterized by a set of signs and symptoms including proteinuria, low protein levels in the blood, hypercholesterolemia, hypertriglyceridemia, and edema. It may be caused by various disorders of the kidney, and the management of the condition varies according to the specific case and the cause of the symptoms.
Acthar Gel may be a viable treatment option for resistant nephrotic syndrome

Acthar Gel may be a viable treatment option for resistant nephrotic syndrome

Halpin Foundation-ASN grant advances research in membranous nephropathy

Halpin Foundation-ASN grant advances research in membranous nephropathy

Questcor's H.P. Acthar Gel sNDA for infantile spasms receives FDA approval

Questcor's H.P. Acthar Gel sNDA for infantile spasms receives FDA approval

Questcor Pharmaceuticals provides update on sNDA for H.P. Acthar Gel

Questcor Pharmaceuticals provides update on sNDA for H.P. Acthar Gel

Widely used cancer drug bevacizumab can lead to proteinuria, kidney damage: Study

Widely used cancer drug bevacizumab can lead to proteinuria, kidney damage: Study

Bevacizumab increases risk for proteinuria in cancer patients

Bevacizumab increases risk for proteinuria in cancer patients

Discovery suggests how toxin-filtering cells go awry

Discovery suggests how toxin-filtering cells go awry

Children with minimal change nephrotic syndrome can be treated with prednisone

Children with minimal change nephrotic syndrome can be treated with prednisone

NIH, NephCure Foundation and University of Michigan support study of nephrotic syndrome

NIH, NephCure Foundation and University of Michigan support study of nephrotic syndrome

Genentech updates on phase III study of Avastin plus chemo in first-line, advanced, non-squamous, non-small cell lung cancer

Genentech updates on phase III study of Avastin plus chemo in first-line, advanced, non-squamous, non-small cell lung cancer

Vermillion issued U.S. patent for method to aid diagnosis of nephrotic syndrome

Vermillion issued U.S. patent for method to aid diagnosis of nephrotic syndrome

Avastin (bevacizumab) shows promise in phase II study of glioblastoma multiforme

Avastin (bevacizumab) shows promise in phase II study of glioblastoma multiforme

How kidneys retain proteins, discard waste

How kidneys retain proteins, discard waste

Children who take steroid drugs for nephrotic syndrome do not suffer bone loss

Children who take steroid drugs for nephrotic syndrome do not suffer bone loss

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.